切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - S-adenosylhomocysteine hydrolase - Adenosine A2A Receptors - Insulin and Insulin-like Receptors - 5-HT2 Receptor

13件产品中的 1-10

页面
每页
清除全部
  1. 3-Deazaadenosine
    B6121 3-Deazaadenosine
    中文名: 3-脱氮腺苷
    Target: S-adenosylhomocysteine hydrolase
    Summary: S-腺苷高半胱氨酸(SAH)水解酶抑制剂
      ≥26.6 mg/mL
      ≥7.53 mg/mL
  2. Regadenoson
    B5904 Regadenoson
     1 Citation
    中文名: 类伽腺苷
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体激动剂
      ≥18.05 mg/mL
      insoluble in H2O
  3. SCH 58261
    B6995 SCH 58261
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体竞争性拮抗剂
      ≥34.5 mg/mL
      insoluble in H2O
  4. SCH 23390 hydrochloride
    B6506 SCH 23390 hydrochloride
    Target: dopamine receptor|5-HT1 Receptor|5-HT2 Receptor
    Summary: 多巴胺受体拮抗剂
      Soluble to 100 mM in sterile water and to 50 mM in ethanol
  5. Methylergometrine maleate
    B6347 Methylergometrine maleate
    中文名: 马来酸甲麦角新碱
    Target: 5-HT1 Receptor|5-HT2 Receptor
    Summary: 5-HT1/5-HT2受体拮抗剂
      Soluble to 25 mM in H2O
  6. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    中文名: 伊曲茶碱
    Target: Adenosine A2A Receptors
    Summary: 选择性A2A受体拮抗剂
      ≥8.78 mg/mL
      insoluble in H2O
  7. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  8. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  9. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  10. Tozadenant
    A3885 Tozadenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷2A受体拮抗剂
      ≥20.35 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页